Figure 4. Change in Diuretic Therapy in Empagliflozin vs Placebo Arms.

HR indicates hazard ratio; py, patient-year.

^aP value for comparison of empagliflozin vs placebo.

^bP trend for comparison of baseline diuretic doses of <40mg, 40mg, and >40mg.

^cFor patients not receiving diuretic therapy at baseline.

^dFor patients receiving diuretic therapy at baseline.